Fractyl Health director buys 64K shares at $0.62

A FRACTYL HEALTH director increased his direct common stock holdings through an open market purchase.

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. (GUTS) director William Bradley reported an open market purchase of common stock. On September 14, 2026, he bought 64,516 shares of common stock at $0.6185 per share. Following this transaction, he directly holds 149,138 shares of FRACTYL HEALTH common stock, and no Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 64,516 shares

Net Buy 1 txn

Insider BRADLEY WILLIAM

Role Director

Bought 64,516 shs ($40K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	64,516	$0.6185	$40K

Holdings After Transaction: Common Stock — 149,138 shares (Direct)

Footnotes (1)

1. F1. Open market purchase

Key Figures

Shares purchased: 64,516 shares Purchase price per share: $0.6185 per share Shares held after transaction: 149,138 shares +1 more

4 metrics

Shares purchased 64,516 shares Open market purchase on September 14, 2026

Purchase price per share $0.6185 per share Open market purchase on September 14, 2026

Shares held after transaction 149,138 shares Direct ownership by William Bradley after the reported purchase

Net shares bought 64,516 shares Net buy activity reported in this Form 4

Key Terms

Open market purchase, Common Stock, Rule 10b5-1

3 terms

Open market purchase financial

"Footnote F1 describes the transaction as an Open market purchase"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Common Stock financial

"The security title for the reported transaction is Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"The document-level Rule 10b5-1 checkbox is not affirmed for this filing"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FRACTYL HEALTH (GUTS) report in this Form 4?

The Form 4 reports that director William Bradley made an open market purchase of 64,516 shares of FRACTYL HEALTH common stock on September 14, 2026 at a price of $0.6185 per share.

How many FRACTYL HEALTH (GUTS) shares does William Bradley own after this transaction?

After the reported transaction, William Bradley directly holds 149,138 shares of FRACTYL HEALTH common stock, as stated in the Form 4.

Was the FRACTYL HEALTH (GUTS) insider trade made under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan is reported for this transaction; the document-level Rule 10b5-1 checkbox is not affirmed.

What was the price paid per share in the FRACTYL HEALTH (GUTS) insider purchase?

William Bradley purchased FRACTYL HEALTH common stock at $0.6185 per share in this open market transaction, according to the Form 4 data.

What type of security did the FRACTYL HEALTH (GUTS) director purchase?

The Form 4 reports a purchase of Common Stock of FRACTYL HEALTH, INC. by director William Bradley in an open market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:05 PM Accepted by SEC EDGAR 09/16/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRADLEY WILLIAM

(Last) (First) (Middle)

3 VAN DE GRAAFF DRIVE

SUITE 200

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		P(1)		64,516	A	$0.6185	149,138	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Open market purchase

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)